New York, NY (PRWEB) September 22, 2014  
    Video: Preventing    Diabetes After Pancreatectomy - Dr. Beth Schrope  
    NewYork-Presbyterian/Columbia University Medical Center now    offers autologous islet cell transplantation, or auto islet    surgery, to prevent diabetes in patients who require a total    pancreatectomy. The hospital is the first center in the New    York metropolitan area to offer this treatment.  
    Every year, roughly 87,000 people in the United States receive    surgical treatment for pancreatitis, a debilitating condition    that causes intense abdominal pain and, potentially, diabetes.    Pancreatitis can be so painful that, in some cases, patients    must have the entire pancreas removed. While surgery relieves    pain in 90 percent of cases, patients are left without the    ability to produce insulin, causing a difficult-to-treat form    of Type 1 diabetes known as brittle diabetes.  
    In auto islet surgery, the patient's islet cells, which produce    hormones that regulate the endocrine system, are extracted from    the pancreas after it is removed. The cells are then processed    and reinfused into the patients liver. When auto islet surgery    is successful, the reinfused cells produce insulin, acting in    place of the pancreas to regulate blood sugar.  
    The most recent findings show that about one third of patients    require no insulin therapy after autologous islet    transplantation, another third require some insulin therapy    after the procedure, and the procedure is unsuccessful in    preventing diabetes in the remaining third.  
    "The goal of pancreatectomy is to relieve pain," says Dr. Beth    Schrope, gastrointestinal surgeon and assistant professor of    surgery, NewYork-Presbyterian/Columbia University Medical    Center, who specializes in the treatment of pancreatitis.    Returning to normal activities and living without pain is a    tremendous improvement in patients' quality of life. Now with    islet transplantation, theres an added bonusthe possible    prevention of diabetes."  
    NewYork-Presbyterian/Columbia University Medical Center is    currently accepting patients for auto islet surgery, through a    joint effort of NewYork-Presbyterian/Columbia's Pancreas Center    and the Stem Cell Processing and Cell Therapy Laboratory of the    Department of Pathology. Patients who need a total    pancreatectomy for benign diseases (such as chronic    pancreatitis) may be eligible for this procedure to avoid Type    1 diabetes.  
    NewYork-Presbyterian Hospital/Columbia University Medical    Center  
    NewYork-Presbyterian Hospital/Columbia University Medical    Center, located in New York City, is one of the leading    academic medical centers in the world, comprising the teaching    hospital NewYork-Presbyterian and its academic partner,    Columbia University College of Physicians and Surgeons.    NewYork-Presbyterian/Columbia provides state-of-the-art    inpatient, ambulatory and preventive care in all areas of    medicine, and is committed to excellence in patient care,    research, education and community service. NewYork-Presbyterian    Hospital also comprises NewYork-Presbyterian Hospital/Weill    Cornell Medical Center, NewYork-Presbyterian/Morgan Stanley    Childrens Hospital, NewYork-Presbyterian Hospital/Westchester    Division, NewYork-Presbyterian/The Allen Hospital and    NewYork-Presbyterian/Lower Manhattan Hospital. The hospital is    also closely affiliated with NewYork-Presbyterian/Lawrence    Hospital in Bronxville. NewYork-Presbyterian is the #1 hospital    in the New York metropolitan area, according to U.S. News &    World Report, and consistently named to the magazines Honor    Roll of best hospitals in the nation. For more information,    visit http://www.nyp.org.  
Go here to read the rest:
New Treatment May Prevent Diabetes After Pancreatitis Surgery